Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Xeris nets FOPO" found in our extensive corporate database of over 50,000 company records.
Xeris is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms to develop and commercialize ready-to-use, room-temperature stable injectable and infusible drug formulations. The companyâs proprietary XeriSolâ¢ and XeriJectâ¢ formulation technologies allow for the subcutaneous (âSCâ) and ...
Citryll is a private pharmaceutical company based in Oss, the Netherlands that is dedicated to the development and commercialization of therapeutics that target NETosis and NETs. Citryll was founded by ModiQuest B.V., originator of the tACPA patents, Helmuth van Es, CEO Citryll, and Renato Chirivi, CSO Citryll and co-inventor of tACPA.
ExcelleRx, Inc. is the market leader in pharmaceutical care for niche disease markets, providing expert medication consultation and pharmaceutical distribution services. Combining proprietary technology and clinical experience, excelleRx ensures the appropriate use of medication, and thereby enhances quality of life. Caregivers from healthcare facilities nationwide rely on excelleRx to manage thei...
DSM Dyneema is the inventor and manufacturer of DyneemaÂ®, the worldâs strongest fiberâ¢ and Dyneema PurityÂ®. DyneemaÂ® and Dyneema PurityÂ® are ultra strong polyethylene fibers that offer maximum strength combined with minimum weight. They are up to 15 times stronger than quality steel and up to 40% stronger than aramid fibers, both on w...